Corvus Pharmaceuticals, Inc. 4
4 · Corvus Pharmaceuticals, Inc. · Filed Jun 10, 2016
Insider Transaction Report
Form 4
Coloma Jason V
SVP, Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-06-08+200,000→ 200,000 totalExercise: $13.34Exp: 2026-06-08→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to twenty-five percent (25%) of the shares subject to the option on June 8, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.